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    THE THESIS EXPLAINED 
 
The biological issue 
Duchenne muscular dystrophy (DMD) is a genetic disease 
characterized by muscle wasting and chronic inflammation. 
Moreover, the continuous cycles of degeneration and regeneration 
and the hostile microenvironment affect the satellite cells function 
and exhaust their regenerative capacity. Previous work done in our 
laboratory showed that lack of PKCQ in mdx mice, the mouse model 
of DMD, improves muscle maintenance, regeneration and 
performance and reduces muscle inflammation. The observed 
phenotype was primarily due to lack of PKCΘ in hemopoietic cells, 
as demonstrated by BM transplantation experiments. Indeed, PKCΘ 
plays a unique role in T cell activation, and represents an attractive 
molecular target for the treatment of immune disorders. The aims of 
this project were to establish whether lack of PKCΘ in dystrophic 
muscle: (1) preserves regenerative ability of resident cell 
populations and (2) improves the survival and the ability of 
transplanted stem cells to generate new muscle fibers and correct the 
genetic defect of the recipient. 
 
Results 
In the present study, I show that the lack of PKCQ in mdx mouse 
boosts muscle regeneration even at advanced stages of the disease 
and prevents fibrosis. This phenotype is associated to a higher 
number of Pax7 positive cells in mdxQ-/- muscle compared with 
mdx muscle, during the progression of the disease. Moreover, I 
found that the Pax7 and Notch signalling, the crucial regulators of 
satellite cell self-renewal, are up-regulated in mdxΘ-/- muscle 
compared mdx muscle. These results suggest that lack of PKCΘ in 
mdx mice preserves the muscle regenerative ability improving the 
satellite cells pool maintenance. Beside satellite cells, lack of PKCQ 
in dystrophic muscle affects also the activity of the fibro-adipogenic 
progenitors (FAPs), preventing FAPs conversion into fibro-
adipocytes and increasing their pro-regenerative activity. 
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Moreover, I show in this study that lack of PKCQ in mdx muscle 
prolongs survival of transplanted mesoangioblasts (MABs) within 
muscle, compared to mdx, and favours their ability to form 
myofibers. 
 
Conclusions  
 
These results demonstrate that lack of PKCQ in dystrophic muscle, 
improves the efficacy of the resident cell populations to repair 
damaged muscle and the engraftment of transplanted stem cells. 
These effects are probably the results of reduced muscle 
inflammation and fibrosis, which may make the microenvironment 
less hostile for the formation of new myofibers from both 
endogenous and exogenous stem cell populations. However, the 
possibility that lack of PKCQ may directly modify muscle cells 
behaviour cannot be ruled out. The underlying mechanisms are 
under investigation and may contribute to the identification of 
additional molecular/ cellular target to ameliorate the disease and to 
improve cell mediated therapeutic strategies. 
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1. INTRODUCTION 
 
1.1 Muscle regeneration 
Skeletal muscle is a dynamic tissue, able to modify its size and 
regenerate following injury. As many other postnatal tissues, the 
regenerative ability of skeletal muscle is due to the pool of resident 
stem cells, which in muscle are called satellite cells. Satellite cells 
were initially identified by Mauro for their location between the 
sarcolemma and the basal lamina of myofibers [1]. Satellite cells are 
quiescent in healthy, grown muscle. However, when muscle is 
damaged, satellite cells are activated, proliferate, and differentiate 
into myofibers while a minor subset self-renew. The muscle 
regenerative process occurs in three main phases: I) inflammatory 
response , II) activation and differentiation of satellite cells and III) 
growth and remodeling of the regenerated muscle tissue [2]. 
- I) inflammatory response: necrotis fibers induce 
inflammatory response that recruit circulating leukocytes. 
Neutrophils are the first inflammatory myeloid cells to 
infiltrate the damaged muscle [3]. Then, two distinct 
subpopulations of macrophages invade the site of the injury: 
M1 (CD68+/CD163-) and M2 (CD68-/CD163-) (Chazaud et 
al., 2009). M1 rapidly increase within 24 hours after injury 
and secrete proinflammatory cytokines such as TNFα and 
IL1. M1 are responsible for the phagocytosis of cellular 
debris and for inducing satellite cell proliferation. M2 
increase at 2-4 days after injury and secrete anti-
inflammatory cytokines such as IL-10, IL4 and IL13. M2 
promote satellite cells differentiation and fusion, but also 
increase collagen production by fibroblasts [4-6].  
- II) activation and differentiation of satellite cells: satellite 
cell activation is governed by several environment factors. 
Upon muscle damage, satellite cells can go through several 
round of amplification and then exit the cell cycle to generate 
a committed population of myoblasts. The committed 
myoblasts fuse to each other to form the new myofibers [7].  
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- III) growth and remodeling of the regenerated tissue: 
Myogenesis and tissue remodeling phases proceed 
simultaneously. The remodeling phase includes the 
production and re-organization of extracellular matrix 
(ECM), revascularization and reinnervation of regenerating 
myofibers.  
 
1.1.1 Satellite cell  
Satellite cells are the principal myogenic stem cell and are normally 
quiescent in adult muscle. Satellite cells self-renewal guarantees the 
muscle ability to regenerate following multiple injuries. Once 
activated, satellite cells can generate functionally different daughter 
cells by asymmetric division: one daughter will go on to 
differentiate after a variable number of symmetric cell divisions, 
while the other will return to the quiescent state, locating between 
the basal lamina end the plasmalemma of the repaired myofibers. As 
shown in Figure 2, the different progenies can be distinguished by 
the expression of Paired box 7 (Pax7) and Myogenic Differentiation 
1 (MyoD): the Pax7+MyoD− expressing cells as the self-renewal 
population, the Pax7+MyoD+ as proliferating and the 
Pax7−MyoD+ as differentiating (Zammit et al., 2004). Pax7 is a 
transcription factor considered as a satellite cell marker. It is 
required for satellite cell specification, maintenance and muscle 
regeneration. Pax7 plays a crucial role in maintaining satellite cell 
quiescence and self-renewal, and is expressed by both quiescent and 
activated satellite cells. In activated satellite cells, Pax7 promotes 
cell cycle exit and return to quiescence, preventing the 
differentiation and ensuring the replenishment of the satellite cell 
compartment during skeletal muscle regeneration[8]. Pax7 null mice 
exhibit normal muscle formation, but reduced postnatal muscle 
growth [9].  The number of satellite cells in Pax7 mutant mice 
strongly declines during postnatal growth and muscle regeneration 
is impaired [10].  Pax-7 overexpression in myoblasts down-regulates 
MyoD expression and transcriptional activity [11]. MyoD is 
considered the myogenic master regulator of the skeletal muscle 
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gene expression program [12]. MyoD activity induces Myogenin 
(MyoG) expression promoting terminal differentiation. The ratio of 
Pax7 and MyoD activities are critical for satellite cell self-renewal 
and myogenic differentiation processes [11].  
 
 
 
Figure 2. a. Satellite cell activation upon muscle injury b Cell-intrinsic factors 
that have roles in satellite cell quiescence, activation and self-renewal [13].  
 
 
Satellite cell fate is mostly determined by the microenvironment. 
Multiple factors within the niche can regulate satellite cell 
activation, differentiation and self-renewal. One of the pathways 
known to be important for the maintenance of diverse types of adult 
stem cells is the Notch signalling[14-16]. Notch is a family of 
transmembrane receptors including Notch1,-2,-3 and -4. The 
interaction with its ligands (Delta-like 1, Delta-like 4, Jagged 1 and 
Jagged 2) induces protease cleavage of the intracellular domain of 
Notch (NICD). NICD is a transcription coactivator that interacts 
with RBPJ and induces its binding to DNA to regulate the 
expression of Notch targets (Hey1, HeyL, Hes) [17]. Also in skeletal 
muscle, Notch signalling appears to be one of the pathway involved 
in regulating satellite cell activation/self- renewal. Notch 1,2 and 3 
are expressed in quiescent satellite cell, while muscle fibres are the 
major source of Notch ligand [18]. Several resident cells, including 
PICs, FAPs and mesenchymal cell, could also be source of Notch-
ligand [16]. It is known that Notch activation prevents myogenic 
differentiation and promotes satellite cell self-renewal, by 
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upregulating Pax7 and inhibiting MyoD [19]. By contrast, the 
inhibition of Notch activity by Numb, a Notch inhibitor, promotes 
myoblast differentiation [20]. In the absence of Notch, satellite cells 
undergo accelerated terminal differentiation without self-renewal, 
resulting in satellite cell depletion [21]. Moreover, Notch signalling 
inhibition in muscle stem cells causes also several muscular 
dystrophic features and impaired muscle regeneration [22]. Notch 
activity is high in quiescent satellite cells and decrease in activated 
myogenic progenitors.  The rapid decrease of Notch activity after 
injury reflects the physiological dissociation of satellite cells from 
the ligand expressed on myofibers. During muscle regeneration, 
temporary decrease of Notch signalling should be necessary to exit 
quiescence and allow amplification of the myogenic population. 
When activated satellite cells return to quiescence, by day 4-5 post-
injury, Notch  activity increases again. The upregulation of Notch 
signalling is crucial to the re-establishment of self-renewed satellite 
cells [18]. During muscle regeneration process, the Notch activity in 
satellite cells could be supported by Delta1 expressed on myofibers. 
Indeed, following injury, Delta1 is up-regulated in committed 
myogenic cells supporting Notch activation in satellite cells. 
Insufficient upregulation of the Notch ligand, Delta-1, following 
injury in old animals leads to a decrease in their regenerative 
potential, which can be restored by forced activation of Notch [23]. 
A possible model of how Notch signalling may regulate satellite 
cells self-renewal is summarized in Figure 3. 
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Figure 3. Notch’s regulation of stem cell fate in muscle. Activated Notch (NICD) 
binds to RBP-J to form a transcriptional activation complex that upregulates the 
transcription of Pax7 and inhibits MyoD, promoting satellite cell self-renewal and 
blocking myogenic differentiation [19]. 
 
 
 
 
 
 
1.1.2 Factors and cell population involved in skeletal muscle 
regeneration 
As summarized in Figure 1, satellite cell activity is regulated by 
several factors which compose their niche. including ECM and local 
cell populations. Alterations in any components of satellite cell 
niche may thus affect the satellite cell functionality.  
 
 
Figure 1.  Signals operating in skeletal muscle stem cell niche [24] 
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ECM 
In general, ECM provides the mechanical support, influences the 
cellular differentiation and operates as a scaffold for nerves, vessels, 
and muscle cells [25]. Moreover, ECM can modulate the satellite 
cells activity by either direct or indirect action. In fact, ECM 
components can establish biochemical gradients by binding growth 
factors, such as FGF and HGF, thus regulating their bioavailability 
[26]. On the other hand, ECM components can directly bind 
receptors on satellite cell surface, mediating their anchorage and 
regulating several signaling pathways[27]. Satellite cells are 
anchored to sarcolemma and basal lamina through α7/β integrins, 
and during the muscle damage, the destroy of basal lamina mobilizes 
the satellite cells contributing to their activation. Several 
components of ECM can affect satellite cells differentiation. Among 
them, it was shown that collagene VI is required for satellite cell 
self-renewal and for the maintenance of satellite cell number 
following multiple muscle injuries [28].  
 
Local cell populations 
Several cell types are involved in the regulation of the satellite cell 
niche during the muscle regeneration. Secreted factors, vesicles, 
microsomes and cell-cell signaling may all contribute to satellite 
cell behavior.   
 
 Endothelial cells. Skeletal muscle has dense microvasculature that 
represented an important component of niche. Indeed, in uninjured 
muscle, most satellite cells are closely associated with capillaries 
[29]. The vascular endothelial cells release vascular endothelial 
growth factor (VEGF) that contributes to satellite cell activation, 
proliferation and myofiber regeneration [30]. Blood vessels 
represent also a source of progenitor cells. Indeed, pericytes are 
mesenchymal cells residing within microvasculature and are 
multipotent progenitor cells. Pericytes can contribute to muscle 
regeneration differentiating into myofibers [31].  
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Immune cells. In uninjured muscle, only a small number of immune 
cells are present. Instead, upon injury, the immune cells are recruited 
in the damaged area and rapidly infiltrate the muscle constituting a 
transient local environment for satellite cells. Inflammatory cells 
remove the necrotic tissue and secrete growth factors, chemokines 
and cytokines, such as IL-1, IL-6, TNF-α, that can promote satellite 
cell activation [32].   
 Interstitial cells. In addition to satellite cells, there are several 
muscle interstitial resident stem/progenitor cell populations able to 
give rise the myofibers. It has been reported that a cell population 
described as PW1+/Sca1+/CD34+/Pax7- (PICs) can spontaneously 
enter myogenic differentiation and contribute to new myofiber 
formation during muscle regeneration [33].  Another interstitial cell 
population involved in muscle repair process are the fibroadipogenic 
progenitors (FAPs). FAPs are able to differentiate into fibroblasts 
and adipocytes [34]. The ability of FAPs to differentiate into 
myofibers is still outstanding statement. In healthy muscle, FAPs 
arelocated in the interstitial space between the myofibers and are 
undifferentiated. After the acute muscle damage, FAPs rapidly enter 
the cell cycle invading the space between the regenerating 
myofibers. During the proliferative phases, FAPs release signals 
inducing the differentiation of primary myoblasts [34, 35]. The 
number of FAPs increases between 3-4 days after the injury, then 
declines, returning to pre-injury level. When regeneration fails, such 
as in muscular dystrophy and chronic damage, FAPs persist in the 
tissue and differentiate into adipocytes and fibroblasts mediating the 
fat and extracellular matrix deposition. It was shown that FAPs 
isolated from dystrophic muscle have a more pronounced ability to 
form adipocytes in vitro compared with FAPs isolated from healthy 
muscle [36, 37]. The chronic muscle diseases are frequently 
characterized by chronic inflammation. Immune cells can regulate 
FAPs proliferation, differentiation and survival. It has been shown 
that the type 2 innate immunity stimulates FAPs to facilitate muscle 
regeneration by the IL4/IL13 signaling. Type 2 cytokine signaling 
promotes proliferation of FAPs and inhibits their differentiation into 
 Piera Fiore 
Pag 14  
adipocytes [38].Also TNF and TGFβ released by macrophages 
modulate FAPs expansion. TNF induces apoptosis of FAPs 
preventing their extended permanence in the tissue and their 
differentiation into fibroblasts and adipocytes, while TGFβ prevents 
FAPs apoptosis and triggers their differentiation [39].  
 
 
 
1.2 Duchenne Muscular Dystrophy 
Duchenne muscular dystrophy (DMD) is a severe form of muscular 
dystrophy affecting up to one in 3,800–6,000 live male births [40]. 
DMD is caused by mutations in DMD gene on the X chromosome 
(Xp21.2) which encodes for dystrophin [41]. Dystrophin is a 
member of dystrophin-associated glycoproteincomplex (DGC) 
localized in the sarcolemma. DGC acts as a bridge between the ECM 
and cytoskeleton and stabilizes the sarcolemma during muscle 
contraction. Lack of dystrophin in muscle fibers causes membrane 
instability increases the probability of damage during contraction 
and leads to fibers degeneration. As a result, dystrophic muscle is 
characterized by persistence inflammation, triggered by cycles of 
degeneration and regeneration. Chronic inflammation impairs 
muscle regeneration and promotes the deposition of fibrotic and 
adipose tissue, which progressively replace the muscle tissue, 
reducing the amount of tissue available for therapeutic intervention 
[29]. DMD patients manifest progressive muscular weakness and 
wasting of various voluntary muscle of the body and die of 
respiratory or cardiac muscle failure in early adulthood. 
 
 
1.2.1 Muscle repair in dystrophic muscle 
In DMD patients, the necrotic fibers are initially replaced by new 
fiber generated by satellite cells. However, the muscle regeneration 
ability rapidly declines with age. In mdx mice, a DMD animal 
model, the muscle repair after injury is impaired compared with WT 
mice (Fig. 4). In DMD patients, muscle regeneration is more rapidly 
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exhausted compared with mdx mice. Worse recovery of dystrophic 
muscles could due to the hostile environment and the exhaustion of 
satellite cell pool. Under normal repair condition, inflammatory 
cells and ECM components provide the molecular factors and 
structural scaffold for generation of new tissue. Pathological 
changes in the muscle environment may impair myogenic function 
of satellite cells. Both human and mouse dystrophic muscle present 
an accumulation of CD4+ and CD8+ T cells, macrophages, 
eosinophils and natural killer T cells infiltrate [42]. Also several 
cytokines and chemokines are present in dystrophic muscle. 
Cytokines have pleiotropic effects and may have pro- or anti-
inflammatory properties. Several different cytokines have effects on 
muscle resident cells during the regeneration process. Among up-
regulated cytokines in dystrophic muscle, TGFb play an important 
role in fibrosis development [43]. After muscle injury, TGFb is 
produced by infiltrating inflammatory cells. TGFb stimulated 
fibroblast to produce collagen and fibronectin and, moreover, 
promotes muscle atrophy [44].  The frequent cycles of degeneration-
regeneration constantly activate the satellite cells.  Continuous 
activation of satellite cells could exhaust the satellite cell pool over 
time. It has been shown that cultured satellite cells from mdx muscle 
display accelerated differentiation compared to non-dystrophic 
satellite cells,  supporting the notion that their proliferative capacity 
is compromised [45]. Together to the impairment of proliferative 
activity, also lack of dystrophin may be responsible for reduced 
muscle repair efficacy in dystrophic muscle.  In fact, dystrophin is 
expressed in differentiated myofibers but also in activated satellite 
cells, where it appears to be  crucial to cell polarity. It has been 
recently shown that lack of dystrophin in satellite cells perturbs their 
polarity leading to impaired asymmetric cell division [46]. The 
impairment of asymmetric cell division leads to reduction of 
progenitors that are able of contributing to muscle repair in the long 
term [46]. Moreover, it was shown that, in dystrophic muscle, the 
decrease in the number of satellite cells during aging is correlated to 
impairment of Notch signalling. Enforced activation of Notch 
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pathway rescued the self-renewal of mdx satellite cells [47]. 
Intriguingly, two Golden Retriever muscular dystrophy (GRMD) 
dogs, the dog model of DMD, with a milder dystrophic phenotype 
was identified. These animals display an increase of expression of 
Jagged1, suggesting that promoting Notch signalling may represent 
a target for DMD therapy in a dystrophin-independent manner[48]. 
In fact, as mentioned before, Notch pathway is involved in 
asymmetric cell division. During cell division, Delta1 and Numb 
have an asymmetric distribution that leads to the asymmetric 
inheritance of Delta 1 and numb in committed daughter cell [20]. It 
remains unknown whether Notch overexpression may restore the 
asymmetric division in dystrophic satellite cells.  
 
 
Figure 4. Skeletal muscle regeneration in acute and chronic injury. Dystrophic 
muscle is characterized by abnormal muscle repair, characterized by extensive 
infiltration of mononuclear cells and fibrosis [49]. 
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1.2.2 Therapies for DMD 
Currently, there is no cure for DMD and treatment is limited to 
glucocorticoids that prolong ambulation but they have more 
negative side effects. Multiple treatment strategies are under 
investigation. Treatment strategies can be divided into two major 
categories: treatment strategies that aim to restore dystrophin 
expression and treatment strategies that aim to compensate for lack 
of dystrophin and counteract the pathology progression by 
decreasing inflammation and fibrosis and promoting muscle 
regeneration [46, 50]. 
 
 
 
Therapies to restore dystrophin expression 
- Exon skipping: is a molecular approach that target the 
specific sequence of pre-mRNA to restore the reading frame 
within the dystrophin gene. Exon skipping acts through 
antisense oligonucleotides (ASOs) that hybridize in a 
complementary manner to pre-mRNA and modulate its 
splicing process. Among the several ASOs investigated, 
2’O-methyl-phosphorothioate oligonucleotide (2’OMetPS) 
and phosphorodiamidate morpholino oligomer (PMO) are 
currently under advanced phase in clinical trials [50].  
- Read-through therapy: aims at suppression of translation 
termination at in-frame premature stop codons to restore 
deficient protein function. Two compounds with read-
through function are being investigated in human patients: 
aminiglicosyde antibiotic gentamicin and atalauren. In the 
studies using gentamicin and atalauren, patients treated had 
a modest increase in dystrophin levels and, moreover 
gentamycin is nephrotoxic. [51, 52]. Novel compounds are 
also investigated.   
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- Gene therapy: several virus vectors are studied to deliver 
functional copies of dystrophin gene. There have been 
developed the adeno-associated virus (AAV)-based 
therapies. AAV vectors are the most used vector for their low 
immunogenicity, the ability to remain stable in 
nonreplicating cells and tropism for muscle.  
- Cell therapy: is a promising clinical option that uses the 
ability of stem cells to differentiate into a specific lineage 
and correct the genetic defect of the recipient. Stem cell 
populations used can be heterologous cells from normal 
donors or be autologous genetically corrected cells. Several 
stem cell populations are being investigated in cell therapies 
for DMD. These populations include myoblasts, CD133+ 
stem cells, pericytes and mesoangioblasts (Mabs)[50]. 
Promising results were reported on intramuscular or intra-
arterial transplantation of Mabs. Mabs are vessel associated 
stem/progenitor cells and are able to differentiate into 
muscle fibers. They possess several receptors for 
inflammatory cytokines that allow them to migrate to 
regions where inflammatory process is ongoing. It has been 
shown that when they are transplanted into the femoral artery 
of dystrophic animals, they are able to cross the vessel wall 
and migrate within skeletal muscle, especially in the area 
where degenerative and regenerative processes are ongoing 
[53, 54]. Current clinical trials are examining the 
effectiveness of Mabs transplantation in the treatment of 
patients with DMD. The phase I/IIa trial of multiple intra-
arterial infusions of HLA-matched donor MABs into five 
DMD patients was reported to be relatively safe but no 
effects on muscle function was observed [55]. Although this 
study appeared somehow discouraging, it provided essential 
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information to modify the plan of future cell therapy 
protocols in DMD patients. As for example, this study 
suggested that immunosuppressive treatment is important to 
preserve Mabs survival but also can reduce the recruitment 
of Mabs in target tissue and the further trials could target 
younger patient, where the fibrosis is less. 
 
 
Therapies that compensate for the lack of dystrophin 
- Anti-inflammatory therapies: the inflammatory response to 
damaged fibers is the main mechanism leading to disease 
exacerbation. At moment, glucocorticoids, such as 
prednisone and deflazacort, are the only pharmacologic 
therapies shown to increase muscle strength and prolong 
independent ambulation, but present several side effects. 
Several potential targets are being investigated to inhibit or 
enhance pro- or anti-inflammatory factors released from 
DMD skeletal muscles. The new potential target could be 
more efficient and have less side effects compared with 
steroidal drugs [56].  
- Epigenetic therapies: Epigenetic mechanisms respond to the 
environment signal through changes in gene expression. 
Epigenetic modifications are essential for development and 
differentiation. Aberrant epigenetic modifications occur in 
several pathologies [57, 58]. It was shown that HDACs are 
involved in the progression of muscular dystrophy in mdx 
mice [59]. Histone Deacetylase Inhibitors (HDACi) 
treatment was reported to improve muscle performance in 
mdx mice, increasing membrane stability and reducing 
inflammatory infiltrate [60].  Most of the beneficial effects 
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of HDACi arise from their ability to inhibit FAPs adipogenic 
potential and promote their myogenic activity [37]. In fact, 
HDACi modulate, in FAPs, the SWI/SNF BAF60 variants 
by up-regulation of myogenic miRs [61]. Phase I/II clinical 
trial of HDACi treatment on children affected by DMD is 
currently ongoing [62]. 
 
 
 
1.3 PKCQ 
PKCQ is a member of PKC family. PKC family includes 12 
isoforms of serine/threonine protein kinases that are subdivided 
into three groups based on their regulatory domains and their 
second messenger requirements for activation: 
- Classical PKCs: α, βI, βII, and γ require phospholipids and 
calcium for activation. 
- Novel PKCs: δ, ε, θ, and η do not require calcium for their 
activation 
- Atypical PKCs: ζ, and ι/λ can be activated in the absence of 
diacylglycerol and calcium 
PKCQ is most abundant in hematopoietic cells, especially T-
cells, platelets, mast cells and natural killers. PKCQ plays an 
important role in t-cell activation, differentiation and survival. 
Indeed, inhibition of PKC-θ is considered as a potential 
immunosuppressive strategy for controlling T cell mediated 
immunity. PKCQ is highly expressed also in skeletal muscle and 
regulates the muscle cell development, homeostasis and 
remodelling [63].  
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      1.3.1 PKCQ in T-cells 
PKCQ is observed in immunological synapse (IS) [64], a T-cell 
specialized membrane microdomain where TCR signalling 
molecules, including the TCR itself, are assembled. Following 
the antigen stimulation of T cell, the signalling from TCR/CD28 
induces the DAG accumulation in plasma membrane, which 
recruits PKCQ to IS (Fig. 5). PKC-θ mediates the activation of 
transcription factors such as NF-κB, AP-1, and nuclear factor of 
activated T cells (NFAT), that are crucial for activation of IL-2 
gene [65-67]. Indeed, PKCQ activity is involved in T-cell 
activation and differentiation in Th2 and Th17 cells. It was 
shown that PKCQ, after t-cell stimulation, can translocate to the 
nucleus and form the chromatic-anchored complex localized to 
the promoter of inducible immune responsive gene [68, 69]. 
PKCQ deficient T-cells display defects in activation, survival 
and differentiation.  
  
Figure 5. PKCQ translocation in immune synapse [70]. 
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Given the central role of T-cells in several immune diseases and 
the crucial role of PKCQ in T-cell fate, PKCQ might be 
considered a selective target for the treatment of immune 
disorder without causing overt immunosuppression. Indeed, it 
was shown that PKCQ deficient mice were resistant to several 
autoimmune syndrome such as myelin oligodendrocyte 
glycoprotein –induced encelophalomyelitis and myosin-induced 
autoimmune myocarditis [71, 72]. Moreover, in cardiac allograft 
experiment, PKCQ deficient mice displayed delayed rejection 
reaction. suggesting that inhibition of PKC-θ can achieving 
long-term survival of allografts [73, 74].  
 
 
      1.3.2 PKCQ in skeletal muscle 
PKCQ is the PKC isoform predominantly expressed in skeletal 
muscle, where it plays multiple roles during development and in 
the adulthood. During development, PKCQ expression was 
detected in fetal myoblast but not in embryonic myoblast, 
suggesting that it is involved in the differentiation of different 
muscle precursors [75, 76]. Actually, embryonic and fetal 
myoblasts display a different sensitivity to TGFb [77], which 
contributes to the asynchronous differentiation during limb 
muscle formation. Embryonic myoblasts are resistant to the 
inhibitory effect of TGFb on myotube formation but forced 
expression of PKCQ prevented myotube formation in the 
presence of TGFβ [75]. Moreover, PKCQ forms a complex with 
nuclear factor one X (Nifx) which  activates fetal and suppresses 
embryonic gene expression, operating as a transcriptional switch 
from embryonic to fetal myogenesis [78]. PKCQ can also 
regulate gene expression regulating HDAC4/5 nuclear export. In 
fact, it was previously shown that in C2C12 muscle cells (a 
myoblast cell line from adult C57 mouse) PKCQ activity led to 
phosphorylation dependent HDAC5 nuclear export favouring 
MEF2 activation [79].  On the other hand, PKCQ activity is 
involved in post-natal muscle growth; in fact, it was previously 
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shown that mice deficient in PKCQ display a delayed body and 
muscle-fiber growth during the first weeks of postnatal life. In 
adult mice, lack of PKCQ delays also myofiber formation after 
injury due to reduced up-regulation of genes involved in fiber 
fusion such as caveolin-3 and b1D- integrin [80]. Although 
PKCQ muscle deficient does not show any morphological 
alterations, it displays altered signalling pathways involved in 
response to environment stimuli.  Indeed, it was also shown that 
lack of PKCQ prevents ER-stress-induced autophagy in starved 
and immobilized muscle [81].  
 
 
      1.3.3. PKCQ in DMD 
As mentioned before, inflammation plays an important role in 
DMD progression. Indeed, several anti-inflammatory strategies 
are proposed for the DMD treatment. In DMD patients and mdx 
mice infiltrating macrophages and T cells are detected in muscle 
during the early stages of disease [82].  Mdx mice treated with 
antibody depleting CD8 or CD4 cells and mdx genetically 
depleted of T and B-cells (scid/mdx mice) present a significant 
reduction of fibrosis suggesting that the T cells activity is crucial 
in dystrophic muscle [83]. In our laboratory, we showed that 
lack of PKCQ in mdx reduced muscle wasting and infiltration. 
Bone marrow transplantation experiments demonstrated that the 
phenotype observed in mdxQ-/- mice is mainly due to the lack 
of PKCQ in hematopoietic cells [84] (Marrocco et al. 
unpublished observation). Indeed, current investigation in the 
laboratory is showing that PKCQ is required for very early T 
cells infiltration in dystrophic muscle, orchestrating the immune 
response (Lozanoscha-Ochser et al ms in preparation). We also 
observed significant improvement in muscle morphology and 
function in mdx mice treated with PKCQ inhibitors (Marrocco 
et al. submitted). Together, these observations make PKCQ an 
attractive target for DMD treatment. PKCQ inhibition, in DMD, 
could not only slow down the progression of diseases but may 
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also favour the efficacy of therapy aiming to restore the 
dystrophin expression. Indeed, cell therapy needs to be 
combined with the appropriate immunomodulation therapy to 
regulate the adaptive immune response. However, it is still 
necessary to better characterize the effect of lack or inhibition of 
PKCQ in immune cell infiltrate in dystrophic muscle. 
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     2. AIMS 
 
2.1 AIM 1: To establish whether lack of PKCΘ in mdx mice 
improves the efficiency of the resident cell populations to 
repair damaged muscle 
Previous results obtained in the laboratory showed that lack of 
PKCQ in 8 week old mdx mice reduced muscle necrosis and 
immune cell infiltrate improving muscle regeneration. It was 
thus proposed that lack of PKCθ makes a more favourable 
environment for muscle precursor cells to differentiate. To 
verify this hypothesis, as first, I wanted to understand whether 
muscle regeneration was boosted in dystrophic muscle lacking 
PKCθ, assessing the kinetics of muscle regeneration and muscle 
degeneration in mdx and mdxQ-/-  mice, during the progression 
of the disease Moreover, I wanted to compare the ability to repair 
damaged muscle following an acute muscle injury in both 
genotypes. In addition, I evaluated the activity of cell 
populations mainly involved in skeletal muscle regeneration: 
satellite cells and FAPs. In fact, satellite cells behaviour changes 
during the progression of DMD and the preservation of their 
self-renewal and regenerative ability is an important therapeutic 
strategy. On the other hand, FAPs are the interstitial muscle cells 
that may participate in muscle regeneration supporting the 
satellite cell myogenic activity, but also in muscle degeneration 
differentiating promoting fibrosis and fat deposition. 
Modulation of FAPs activity is thus proposed to improve muscle 
repair. 
 
 
 
2.2 AIM 2: To establish whether lack of PKCΘ in mdx mice 
improves the engraftment of transplanted stem cells 
Since PKCΘ has been shown to play a key role in the 
development of autoimmune disease and in allograft rejection, I 
aimed to verify whether its inhibition may contribute to the 
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effectiveness of cell therapy in dystrophic muscle, promoting the 
survival of transplanted cells. To this aim, I wanted to verify 
engraftment and survival of transplanted beta-gal expressing 
mesoangioblasts in mdx muscle lacking PKCQ, compared to 
mdx  
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     3. RESULTS 
 
3.1 Lack of PKCΘ improves muscle repair and promotes 
satellite cell pool maintenance in mdx mice  
 
3.1.1 Lack of PKCΘ reduces the muscle degeneration in mdx 
mice and boosts the muscle regeneration  
It is well known that in mdx mice, the progression of the disease 
follows distinctive phases of muscle degeneration and regeneration. 
Up to two weeks of age, the muscle morphology is similar in mdx 
and healthy mice. The process of muscle degeneration starts at 3 
weeks of age and peaks at 4 weeks. The high level of muscle 
degeneration is followed by high levels of muscle regeneration. 
From 3 months of age, both the cycles of degeneration and 
regeneration are attenuated and the skeletal muscle enters a stable 
phase [82, 85].  
Previously we showed that lack of PKCΘ in mdx mice at 2 month 
of age prevented muscle wasting and improved muscle regeneration, 
maintenance and performance. I here analyzed muscle degeneration 
and regeneration at different ages in mdx and mdxΘ-/- mice to 
characterize the kinetics of disease in both genotypes. Muscle 
degeneration was evaluated in tibilis anterior (TA) as the extent of 
damage area in H&E stained cryosection, while muscle regeneration 
as the extent of area positive for embryonic myosin heavy chain 
(eMHC) immunostaining.   
As shown in Figure 6, muscle damage was very high in 4week old 
mdx mice, as expected, to suddenly drop down by 6 weeks of age; 
after this age, muscle damage continued to slowly decrease, up to 12 
months of age. By contrast, muscle damage was much lower in 4 
week old mdx mice lacking PKCΘ, and this low level was 
maintained throughout the ages, besides a slight increase at 6 months 
of age. On the other hand, in mdx muscle, the high level of muscle 
regeneration observed at 4 weeks of age, dropped drastically by 6 
weeks and continued at very low level until 12 months of age.  In 
mdxΘ-/- muscle the level of muscle regeneration was low but 
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persistent throughout the ages. Expressing these results as the ratio 
of regenerating area over damage area, in mdxΘ-/- muscle the ratio 
is higher at all the ages examined, suggesting that the regeneration 
process is boosted compared to mdx during the progression of the 
disease.  
 
 
Figure 6. Muscle degeneration and regeneration kinetics in mdx and mdxΘ-
/- mice. A Muscle degeneration was quantified as the percentage of damaged area 
over the total area in H&E stained TA cryosections. B. Muscle regeneration was 
quantified as the percentage of eMHC positive area over total area of TA 
cryosections. C. Ratio of regenerating area on damaged area. The results are 
mean±SEM  (n= 4-5 for each age; *P<0.05 two-tailed Student’s t-test). 
 
 
During the progression of disease, the chronic damage and 
inflammation is known to lead to an increase in fibroblast ECM 
production that gives rise to the fibrotic tissue. Fibrosis is one of 
most deleterious aspects of DMD since the aberrant deposition of 
ECM limits the amount of contractile muscle tissue [86]. I thus 
analyzed the collagen deposition in TA muscle derived from mdx 
and mdxΘ-/- mice at different ages. The Masson’s trichrome 
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staining of TA sections (Fig. 7) showed a significant increase of 
collagen deposition in mdx mice compared to WT mice at 6 weeks, 
as expected. The difference in collagen deposition between mdx and 
WT increased further at 6 and 12 months. By contrast, the lack of 
PKCΘ partly prevented  the collagen deposition in mdx muscle, at 
the examined ages. The decreased deposition of ECM components 
in dystrophic muscle should therefore preserve the architecture and 
the functionality of muscle tissue, and assure the correct and 
complete repair process after the injury. 
 
 
 
Figure 7. Fibrosis accumulation is reduced in mdxΘ-/- muscle compared with 
mdx. A Representative images of Masson’s trichrome staining of cryosections 
derived from WT/, mdx and mdxΘ-/- TA muscle at 6 weeks, 6 and 12 months. B. 
Fibrosis was quantified as percentage of Masson’s trichrome positive area per 
field of view in TA section.(*P<0.05, **P<0.01, ***P<0.001 two-tailed Student’s 
t-test). 
 
 
 
3.1.2 The muscle repair after injury is improved in mdxΘ-/- 
compared with mdx mice.  
The continuous cycles of degeneration and regeneration and the 
hostile dystrophic environment are believed to exhaust the 
regenerative capacity. Indeed, after acute injury, the muscle repair 
is impaired in mdx mice compared with WT mice [87] and gets even 
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worse with the ages [47]. We thus wondered whether lack of PKCΘ 
may improve the regenerative ability of dystrophic muscle upon 
muscle injury. TA muscle of 6 month old WT, mdx and mdxΘ-/- 
mice were injured by cardiotoxin (CTX) injection. It has been 
previously shown that CTX-stimulated increase of satellite cells is 
prevented in 6 month old mdx mice [47]. The mice were sacrificed 
7 days after CTX injection and the number of regenerating 
myofibers, identified as the centrally nucleated fibers, was counted 
in H&E stained section of TA muscles. As expected, the number of 
regenerating fibers in the damaged area was lower in dystrophic 
muscle compared with WT muscle (Fig. 8). By contrast, a 
significant higher number of regenerating fibers was found in TA 
muscle derived from mdxΘ-/- mice compared with mdx. Skeletal 
muscle repair following injury requires also the deposition, 
remodelling and reorganization of ECM. ECM deposition occurs 
within a week post-injury and it can go on for several weeks, to 
ensure complete repair. However, in cases of chronic injuries, such 
as in dystrophic muscle, the newly generated ECM can transform 
into scar tissue [88]. As shown in Figure 8, at 7 days after CTX 
injury, the amount of ECM deposition in the injured area was greater 
in the mdx mice than WT mice, as expected. However, lack of 
PKCQ partly prevented ECM deposition in mdx mice.  Together 
these results suggest that the lack of PKCΘ in dystrophic muscle 
preserves the ability of skeletal muscle to repair the damaged area. 
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Figure 8 Muscle regeneration upon injured is improved  in  mdxΘ-/- mice 
compared with mdx. Representative images of TA stained with H&E (A) and  
Masson’s trichrome staining of 6 month old WT/bl10, mdx and mdxΘ-/- mice at 
7 days after CTX injury (B). Average of number of regenerating fibers (C) and 
quantification of collagene deposition (D) per field of view. (*p<0.05, **p<0.01,  
two-tailed Student’s t-test). 
 
 
 
3.1.3 Lack of PKCΘ in mdx mice preserves the self-renewal 
ability of satellite cells. 
Given the reduction of muscle damage during the early stages of 
disease in mdxΘ-/-, we wondered whether the improvement of 
repair ability was due to more efficient maintenance of satellite cell 
pool compared with mdx mice. In fact, it is believed that in muscular 
dystrophy the continuous rounds of damage can exhaust the self-
renewal ability of satellite cells [87]. In the early stage of muscle 
repair process, quiescent MuSCs migrate to the site of injury and 
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proliferate. Following the proliferation phase, a subset of MuSCs 
undergoes myogenic differentiation, downregulating Pax7 
expression and upregulating MyoD expression. Another subset of 
proliferating MuSCs mantains Pax7 expression, instead, and returns 
to a quiescent state ensuring the long-term self-renewal [89-91].  
Since MuSC self-renewal may be improved in dystrophic muscle 
lacking PKCQ, it is conceivable that the observed improved 
regeneration was due to maintenance of satellite cells number within 
mdxQ-/- muscle. The number of total Pax7 positive cells in TA 
section from mdx and mdxΘ-/- mice at different ages, was then 
counted. As shown in Figure 9, the number of Pax7 positive cells 
was significantly higher in TA muscle from mdxΘ-/- than mdx mice 
at any  of the examined age (Fig.9). 
 
 
            
Figure 9. Lack of PKCΘ in mdx mice increases the number of Pax7 positive 
cells in vivo.  Number of Pax7+ cells in TA section of mdx and mdxΘ-/- mice at 
6weeks, 12 weeks, 6 and 12 months of age. The number of Pax7+ cells was 
calculated by counting the number of PAX7+ cells per field of view in immune-
stained sections. The results are the means±STDEV for three different mice in 
each genotype at different ages. (*p<0.05, **p<0.01, two-tailed Student’s t-test). 
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Further, we found, by qRT-PCR analysis, that the level of 
expression of Myogenin, was higher in mdxΘ-/- mice compared 
with mdx mice at 12 months of age (Fig.10). Myogenin expression 
is up-regulated in differentiating satellite cells, and it is considered 
as a marker of muscle regeneration. This increase was not observed 
in muscle derived from PKCQ-/- as compared with WT, suggesting 
that it is a consequence of lack of PKCQ specifically in dystrophic 
muscle. Together, these results demonstrate that lack of PKCΘ in 
mdx mice increases the number and the regenerative ability of 
satellite cells, compared with mdx 
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Figure 10. Increased Myogenin level in mdxΘ-/- mice at 12 months of age.  
Myogenin mRNA levels in PKCΘ-/-, mdx and mdxΘ-/- TA muscle was 
normalized to those in WT/bl10 TA muscle. (*p<0.05, two-tailed Student’s t-test). 
 
Together, these results suggest that lack of PKCθ in dystrophic 
muscle improves MuSCs self-renewal, thus maintaining muscle 
regenerative ability. Several factors pathways are involved in 
MuSCs self-renewal. Many studies showed that Notch signalling is 
essential for maintenance of satellite cell pool and is perturbed in 
ageing and muscle diseases [23, 47, 92]. 
 To study the effect of lack of PKCΘ in dystrophic muscle on 
satellite cell function, I isolated the MuSCs from limb muscle of 6 
week old mdx and mdxΘ-/-  mice by FACS to analyse the gene 
 Piera Fiore 
Pag 34  
expression involved in satellite cell self-renewal. We choose 6 
weeks of age because this is the age when muscle regeneration starts 
to decline in mdx muscle. MuSCs were isolated as Ter119-/ CD45-/ 
CD31-/ CD34⁺/ α7-integrin ⁺/ Sca-1‾ cells . The expression level of 
Pax7, MyoD, Notch1-2-3, Delta1 and Numb was then analysed by 
qRt-PCR analysis. As shown in Figure 11A, Pax7 and Notch1 level 
of expression was significantly higher in MuSCs freshly isolated 
from mdxΘ-/- mice compared with those isolated from mdx mice. 
An aliquot of the sorted cells was cultured for 62hrs, instead, and 
analysed for the expression of PAX7 and MYOD by 
immunofluorescence.  Based on the expression of PAX7 and 
MYOD, cultured satellite cells are defined as self-renewing 
(Pax7+/MyoD-), activated (Pax7+/MyoD+) or differentiating (Pax7-
/MyoD+) [93, 94]. As shown in Figure 11B-C, the percentage of 
Pax7+/MyoD- “self-renewing” cells over the total number of cells, 
was higher in MuSCs derived from in mdxΘ-/- muscle than mdx. 
The higher level of expression of Pax7 and Notch1 in MuSCs 
isolated from mdxΘ-/- muscle compared with mdx, together with 
the higher number of Pax7+/MyoD- when MuSCs isolated from 
mdxΘ-/- muscle are cultured, suggest that in lack of PKCQ in mdx 
preserves the self-renewal of MuSCs. 
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Figure 11. Lack of PKCΘ in dystrophic muscle improves the self-renewal 
capacity of MuSCs. A Sorted MuSCs were analysed for the level of expression 
of Pax7, MyoD, Notch receptors, Delta1 and Numb by qRT-PCR. RNA 
expression level in mdx and mdxΘ-/- MuSCs was normalized to those in WT/bl10 
MuSCs. Samples represent duplicate experiment of pooled RNA from MuSCs 
sorted from three mice for each sample. (*p<0.05, **p<0.01,  two-tailed Student’s 
t-test). B Representative images of Pax7 (green) and MyoD (red) 
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immunofluorescence of MuSCs, isolated from mdx and mdxΘ-/- muscle and 
cultured for 62h. Nuclei were counterstained with Hoechst (blue). C Percentages 
of Pax7+/MyoD- and Pax7+/MyoD+ cells over the total number of nuclei. The 
results are mean±STDEV (n=3/genotype). 
 
Notch signalling in satellite cells is activated by the binding of Notch 
receptor with Jagged and delta1, known ligand of Notch, expressed 
mainly on the myofiber surface. It is known that Delta1 decrease in 
aged and dystrophic muscle [23, 47]. I thus analysed the expression 
level of Delta1 in TA muscle derived from mdx and mdxΘ-/- by 
qRT-PCR analysis. As shown in Figure 7, Delta1level of expression 
is significantly higher in TA muscle derived from mdxΘ-/- than that 
from mdx muscle at 6 and 12 weeks and at 12 months (Fig. 12). The 
high Delta1 level of expression in mdxΘ-/- may suggest an active 
role of myofibers to boost the self-renewal process by Notch 
signalling. Interestingly, no increase of Delta1 level of expression 
was observed in muscle derived from 6mo old mdx/theta- compared 
to age-matching mdx. As shown before, in mdxΘ-/-  mice, muscle 
degeneration peaks at 6 months of age, which may temporarily 
compromise myofiber quality. 
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Figura 12.  Increased Delta1 level in mdxΘ-/- mice at different ages.  Delta1 
mRNA level in mdx and mdxΘ-/- TA muscle was normalized to those in WT/bl10 
TA muscle. (*p<0.05, two-tailed Student’s t-test). 
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To verify whether PKCQ is directly regulating Delta1 expression 
we analysed Delta1 expression in TA muscle derived from WT/bl6 
and PKCΘ-/- mice. In healthy non-dystrophic muscle, Delta1 
expression was similar in WT and PKCΘ-/- (Fig. 13A). However, 7 
days after CTX-induced muscle injury, the level of expression of 
Delta1 was higher in PKCΘ-/- muscle compared with WT (Fig.13b). 
These results suggest that PKCQ modulates Delta1 expression in 
regenerating myofibers, and its lack results in increased Delta1 
expression, which, in turn, may favour MuSCs self-renewal. 
 
 
         
Figura 13. Lack of PKCΘ increases the levels of Delta1 expression after 
injury. A qRT-analysis of Delta1 expression in WT and PKCΘ TA muscle . B 
qRT-analysis of Delta1 expression in WT/bl6 and PKCΘ TA muscle at 3and 7 
days after CTX injury 
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3.1.4 Lack of PKCΘ in dystrophic muscle changes the 
differentiation fate of FAPs and improves their pro-
myogenic activity 
Since lack of PKCQ in mdx improve muscle regeneration, I 
wondered whether it may affect the activity of FAPs. FAPs are 
interstitial cells involved in both muscle regeneration and muscle 
degeneration. Indeed, during muscle chronic diseases can mediate 
fat and ECM deposition.  
FAPs were isolated by FACS from limb muscles of 6 week old mice 
as Ter119−/CD45−/CD31−/CD34+/α7-integrin−/Sca-1+ cells. As 
first the expression level of PKCQ was analysed, by Western blot 
analysis, in FAPs isolated from mdx mice and cultured in either 
growth or adipogenic differentiation medium. As shown in Figure 
14, PKCQ was expressed in both culture conditions. 
 
 
 
Figure 14. PKCQ expression in FAPs. Western blot analysis of FAPs isolated 
from mdx muscle and cultured in growth medium (GM) or adipogenic 
differentiation medium (DM). Whole muscle protein lysates from WT and PKCQ-
/- mice were used as positive and negative control. 
 
 
 
To verify whether lack of PKCQ may alter the expression level of 
other PKCs, whose activity may affect FAPs behaviour, the 
expression level of PKCα, PKCδ and PKCε was determined  in 
FAPs isolated from mdx and mdxQ-/- by qRT-PCR analysis.-. As 
shown in Figure 15, the absence of PKCΘ in the FAPs did not appear 
to change the level of expression of the other PKCs.  
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Figure 15. PKC expression in FAPs. FAPs were analysed for levels of 
expression of  PKCα, PKCδ, PKCε by qRT-PCR. RNA expression levels for each 
gene was normalized to those of PKC in whole WT muscle.  
 
 
Since FAPs are known to functionally interact with MuSCs and to 
regulate each other behaviour, we wonder whether lack of PKCΘ in 
mdx muscle, may affect functional interactions between FAPs and 
MuSCs.  We used ex vivo trans-well co-culture system, since it is 
known that FAPs enhance the differentiation rate of MuSCs in co-
culture [34]. FAPs and MuSCs were isolated from muscles of 
mdxΘ/- or mdx. MuSCs from mdx or from mdxQ-/- were plated in 
the bottom chamber, while FAPs from the same genotype or from 
the other were plated on the upper chamber. The effect of FAPs on 
intrinsic myogenic potential of MuSCs was determined by MyHC 
staining after 7 days of co-culture in growth medium and quantified 
by fusion index. As shown in Figure 16, MuSCs fusion index, 
derived both from mdx and mdxΘ-/- muscle, was further increased 
when co-cultured with FAPs isolated from muscles of mdxΘ-/-  
compared with FAPs isolated from mdx (Fig. 16). These results 
demonstrate that lack of PKCQ in dystrophic muscle enhances FAPs 
myogenic potential. 
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Figure 16. Functional interactions between FAPs from mdx and mdxΘ-/-
muscle and MuSCs from mdx and mdxΘ-/muscle. A Representative 
immunofluorescence images of co-culture stainred for MyHC and DAPI. B 
Fusion rate was determined as the percentage of nuclei contained in myotubes 
(containing ≥ 3 nuclei) with respect to the total number of nuclei. The results are 
mean±STDEV  for three different experiments. (*p<0.05, two-tailed Student’s t-
test). 
 
 
 
To evaluate the eventual “global” changes in gene expression 
induced by lack of PKCQ in FAPs, the transcriptome of FAPs 
freshly isolated from muscle of mdx and mdxΘ-/- mice, was 
analysed by RNAseq. FAPs sorted from 4 mice/genotype were 
pooled to generate one sample and two samples for genotype were 
used for RNAseq analysis. As shown in the heat map (Fig.17a), 
there were few differentially expressed genes comparing FAPs from 
mdx and mdxQ-/-. A total of 138 genes were significantly 
differentially expressed between the samples. Among them, 117 
were upregulated while 21 were downregulated in FAPs from 
mdxQ-/- muscle compared with mdx. Among the identified 
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transcripts, transcripts of genes involved in muscle determination 
and differentiation, such as Pax7, MyoD and Myf5, were up-
regulated in FAPs isolated from mdxΘ-/- mice, compared to those 
isolated from mdx mice.  By contrast, no changes in the expression 
level of genes involved in adipogenic differentiation, such as C-
Ebpb, Pparg, Adiponectin and Perilipin) were observed. Moreover, 
we found that Kdm6b (also called JMJD3) and Smyd1 are up-
regulated in FAPs from mdxQ-/- muscle (Fig.17C). Kdm6b and 
SmyD1 are involved in histone modification. Kdm6b mediates the 
removal of repressive trimethylation of histone H3 at lysine 27 
(H3K27me3) while SmyD1 mediates the activate methylation 
histone H3 at Lys-4 (H3K4me). Although these results need to be 
validated, they suggest that lack of PKCQ in dystrophic muscle 
modifies FAPs fate and plasticity, up-regulating muscle specific 
genes.  
 
 
 
 Piera Fiore 
Pag 42  
 
Figura 17. The transcripts of genes involved in muscle determination and 
differentiation are up-regulated in FAPs isolated from mdxΘ-/- mice. A 
Hierarchical clustering analysis of gene expression profiles in FAPs isolated from 
mdx and  mdxΘ-/- muscle using log2 ratios. Each column presents one sample 
and each horizontal line refers to a gene. Color legend is on the top of the heatmap. 
The intensity represents the magnitude of the difference. The yellow tiles 
represent downregulated genes and blue tiles indicate upregulated genes. B The 
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enrichment of up and down-regulated genes for each biological category. C The 
enrichment of up regulate genes for each protein class. 
 
To characterize the differentiation potential of FAPs isolated from 
muscles of mdx and mdxΘ-/- mice, the FACS-purified FAPs were 
cultured in adipogenic differentiation medium or in myogenic 
differentiation medium. The adipogenic potential was measured by 
Oil red O staining, while the myogenic potential was measured by 
MyHC immunostaining.  As shown in Figure18, FAPs isolated from 
mdxΘ-/- mice showed reduced ability to differentiate into Oil red-
positive adipocytes compared with mdx mice; surprisingly, when 
cultured in myogenic differentiation medium, FAPs derived from 
mdxQ-/-, but not to FAPs derived from mdx, are able to differentiate 
into myotubes. We cannot exclude that the up-regulation of the 
expression of myogenic genes in freshly isolated FAPs and the 
formation of myotubes in the culture of FAPs from mdxQ-/- could 
be due to contamination with MuSCs during FACS sorting. 
However, it is unlikely that the FAPs isolated from mdxQ-/- are 
consistently more contaminated in all the experiments.  
 
 
Figura 18. Differentiation potential of FAPs from mdx and mdxΘ-/- muscle. 
A Representative images of Oil Red O staining in FAPs cultures. B Quantification 
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of red oil area, reported as pixel2/field. C Representative images of MyHC (green) 
immunofluorescence in FAPs cultures. Nuclei were counterstained with DAPI 
(blue). D Number of MHC positive nuclei per well. 
 
To further analyse these aspects, FAPs isolated from 6 week old 
mdx mice were cultured in presence or not of the  PKCQ inhibitor 
,C20 (Marrocco et al 2016), prior the exposure to differentiation 
media. Isolated FAPs were treated with increasing concentrations of 
C20 (0,5µM, 1µM and 5µM) 15 hours before induction of either 
adipogenic or myogenic differentiation. As shown in Figure19, C20 
treated FAPs did not show statistically significant differences in the 
ability to differentiate into adipocytes compared with untreated 
FAPs. By contrast, FAPs treated with 1µM C20 showed a significant 
increase of ability to differentiate in myotubes compared with 
untreated FAPs. This results suggest that the inhibition of PKCQ 
could directly affect the differential fate of FAPs and promotes their 
myogenic differentiation.  
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figure 19. Differentiation potential of C20 treated FAPs. A Representative 
images of Oil Red O staining in FAPs cultures. B Representative images of MyHC 
(green) immunofluorescence in FAPs cultures. Nuclei were counterstained with 
DAPI (blue).C Quantification of red oil area, reported as pixel2/field. D Fusion 
rate was determined as the percentage of nuclei contained in myotubes (containing 
≥ 3 nuclei) with respect to the total number of nuclei. The results are 
mean±STDEV  for three different experiments. (*p<0.05, two-tailed Student’s t-
test 
 
 
 
3.2. Lack of PKCΘ in mdx mice modifies the muscle 
environment to improve the engraftment of transplanted 
stem cells. 
Given the improvement of regenerative capacity of resident stem 
cells in mdxΘ-/- mice and the role of PKCΘ in T cells and allograft 
rejection [73, 95], we wondered whether lack of PKCΘ could 
improve also the regenerative activity of exogenous stem cells 
improving the efficacy the stem cell engraftment. To this aim, we 
used MABs as exogenous stem cells.   
 
 
3.2.1 MABs recruitment in mdx muscle is not affected by lack 
of PKCΘ 
To verify whether lack of PKCΘ in the dystrophic muscle 
environment can be beneficial to graft transplant, 5x105 nuclear β-
Galactosidase expressing Mabs (nLacZ-Mabs) were intrarterialy 
transplanted into 6 week old mdx and mdxΘ-/-. Three days after 
injection,  mice were sacrificed and TA muscles were collected to 
analyse  the presence of β-gal expressing cells in cryosections and 
the level of expression of LacZ mRNAby qRT-PCR analysis. 
Surprisingly, we found that the number of nLacZ-Mabs and of 
nLacZ expression were higher in mdx than in  mdxΘ-/- (Fig. 20) .  
However, given that trafficking, adhesion and infiltration of Mabs is 
regulated by the signals released by the damaged inflamed muscle, 
this result may depend on the different level of inflammation and 
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damage within the dystrophic muscle expressing or not expressing 
PKCΘ.   
 
Figure 20.  Mabs recruitment in injured TA muscle derived from mdx and 
mdx Θ-/-   TA 72h after Mabs injection into femoral artery. A Representative 
staining for X-gal activity in TA cryosections derived from mdx and mdx Θ-/-  . 
B qRT-PCR analysis of LacZ expression in the same samples. 
 
To verify whether the lower recruitment was due to the lower levels 
of degeneration and inflammation or to lack of PKCΘ in the 
environment, nLacZ-Mabs were transplanted in injured WT an 
PKCΘ-/- mice. TA muscles of WT an PKCΘ-/- were damaged by 
cardiotoxin or by freeze injury. After 24 hrs 5x105 nLacZ-Mabs 
were injected into the femoral artery. The mice were sacrificed 1 and 
3 days after transplantation. As shown in Figure 21, 24 hrs after 
transplantation, the number of nLacZ-Mabs and nLacZ mRNA 
within the injured muscle appeared to be similar in WT an PKCΘ-/- 
mice.  By contrast, when mice were sacrificed  3 days after intra-
arterial Mabs transplantation, nLac-Mabs were detectable only in 
TA muscle derived from PKCΘ-/-  mice, but not in that from WT, 
as revealed by both histochemistry and qRT-PCR for  nLacZ 
expression. These results support the idea that lack of PKCΘ does 
not affect Mabs recruitment in damaged area, but it may favour the 
survival of transplanted cells. 
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Figure 21. Mabs recruitment in injured TA muscle derived from WT and 
PKCΘ-/-   24 and 72h after Mabs injection into femoral artery. A 
Representative staining for X-gal activity in TA cryosections derived from  WT 
and PKCΘ-/-. B qRT-PCR analysis of LacZ expression in the same samples 
 
 
 
3.2.2 Lack of PKCΘ improves Mabs survival and 
differentiation in myofibers in injured and dystrophic 
muscle. 
To analyse the survival of transplanted Mabs, Mabs were 
transplanted via intra-muscular injection to prevent any differences 
due to recruitment. In particular, TA muscle of WT and PKCΘ-/-  
mice was first damaged by freeze-injury. 24 hours after muscle 
injury, 5x105 nLacZ-Mabs were transplanted via intramuscular 
injection. The mice were sacrificed 1, 3, 6 and 14 days after 
transplantation.  As shown in Figure 22,  the number of nLacZMabs 
within the injured muscle appears to be similar in WT and PKCΘ-/- 
mice up to 6 days after transplantation. 14 days after transplantation, 
nLacZ-Mabs were detectable in TA muscle derived from PKCΘ-/-  
mice, but not in that from WT. Moreover, LacZ positive nuclei were 
localized within muscle fibers, showing that transplanted Mabs 
contributed to the formation of regenerating myofibers. 
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Figure 22. Time course of Mabs survival in injured TA muscle derived from 
WT and PKCΘ-/-  following intra-muscular injection.  Representative 
cryosections of TA muscle derived from WT and PKCΘ-/-   sacrificed 1, 3, 6 or 
14 days after transplantation, as indicated and  assayed for X-gal activity 
 
 
We then analysed the survival of transplanted Mabs in dystrophic 
muscle. Mabs were transplanted via intra-muscular injection in TA 
muscle of 6 week old mdx and mdxΘ-/-  mice. The mice were 
sacrificed  3,  7, 14 and 30 days after transplantation. As in non-
dystrophic background, the number of nLacZ/Mabs within the 
muscle appeared to be similar in mdx and mdxΘ-/-  mice 3 and 7 
days after transplantation; however, we LacZ positive nuclei in mdx 
mice were mostly localized in the interstium, while were mostly  
found within muscle myofibers in mdxΘ-/- mice (Fig.23). This 
results may suggest that the muscle environment in mdxΘ-/- mice 
improves Mabs ability to fuse  in muscle fibers compared with mdx 
mice. Importantly,  14 days after transplantation, nLacZ/Mabs were 
detected in muscle derived from mdxΘ-/- mice, but not from mdx 
mice. 30 days after transplantation no lacZ positive nuclei were 
found in both mdx and mdxΘ-/- mice. Together these results 
demonstrate that lack of PKCQ prolongs survival and sustains 
differentiation of transplanted MABs, probably because of the 
reduced inflammatory environment. However, the MABs we used 
expressed the bacterial beta-galactosidase. It is thus possible that, 
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since lack of PKCΘ affects T cells activity modulating the adaptive 
immune response but not the acute immune response, it may not 
prevent rejection to antigens of bacterial origin.  
 
 
Figure 23. Time course of Mabs survival in injured TA muscle derived from 
mdx and mdxΘ-/-  following intra-muscular injection.  Representative 
cryosections of  TA muscle derived from mdx and mdxΘ-/-   sacrificed 3,7, 14 or 
30 days after transplantation, as indicated and  assayed for X-gal activity 
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4. DISCUSSION 
 
The present study shows that the lack of PKCQ in mdx mice, 
improves muscle repair promoting satellite cell pool maintenance,  
myogenic and pro-myogenic activity of FAPs and favours the 
engraftment of transplanted stem cells. In our laboratory it has been 
previously shown that lack of PKCΘ reduced muscle loss and 
inflammatory infiltrate and increased muscle performance in 8 week 
old mdx mice. Analysing the degeneration and regeneration level at 
different stages of the disease in mdx and mdxQ-/- muscle, I found 
that the high level of muscle damage observed in 4week old mdx 
mice, is almost blunted in mdxQ-/- mice and collagen deposition is 
partly prevented during the progression of the disease, when 
compared with mdx mice. By contrast, the area of regenerating 
myofibers, compared to degenerating area, is increased at different 
ages in mdxQ-/- mice compared to mdx muscle. Increased 
regeneration was also observed, after acute injury, supporting the 
hypothesis that myogenic ability of endogenous cell populations is 
maintained and promoted in the absence of PKCQ. These results 
might appear in contrast to our previous observation that lack of 
PKCΘ delayed muscle repair after freeze-injury in non-dystrophic 
background. However, we also showed that the observed delayed 
muscle repair was not associated to reduced activity of satellite cells, 
rather to the delay in the addition of fusing cells to regenerating 
myofibers, a process known as “secondary fusion” [80]. In the 
dystrophic background, impaired muscle repair is rather due to 
impaired satellite cells activation and maintenance. Thus, the 
different muscle regenerative ability of mdx and mdxQ-/- could be 
due to the different behaviour of satellite cells due to different 
quality of environment. I show here that lack of PKCQ blunts the 
early peak of muscle degeneration in mdx, which, in turn, may 
prevent the exhaustion of satellite cell pool and preserve their self-
renewal ability. Indeed, I show that: 1.  the number of Pax7 positive 
cells in muscle is higher in mdxQ-/-mice compared with mdx mice, 
and 2. the level of Pax7 and Notch1expression in satellite cells 
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isolated from muscle derived from mdxQ-/- mice is higher 
compared with those from mdx. Notch1 signalling is known to be 
required for maintaining regenerative ability and self-renewal of 
satellite cells. It is well known that Notch signalling declines in aged 
mice and in muscular dystrophy [23, 47]. Notch signalling is 
activated by the interaction of Delta or Jagged ligands to Notch 
receptors at the level of cell membrane. After injury, Notch ligands 
are upregulated on the myofiber surfarce, suggesting that the 
activation of Notch signalling is crucial during the muscle repair. 
Satellite cells are directly attached to myofibers and Notch ligand on 
myofibers should activate Notch signalling in satellite cells. 
Interestingly, I found that in mdxQ-/- muscle Delta1 expression is 
higher than mdx muscle suggesting that the myofibers could support 
the Notch signalling in satellite cells. In basal condition, PKCQ 
doesn’t affect Delta1 expression level; in fact, its expression is 
similar in WT and PKCQ-/- muscle. In contrast, after the acute 
injury, the level of Delta1 expression is higher in PKCQ-/- muscle 
compared with WT muscle, suggesting that the PKCQ could directly 
affect Delta1 expression level after the injury. This observation 
suggests that the up-regulation of Delta1 expression is due to lack 
of PKCQ in myofibers and not to the different muscle environment. 
In fact, lack of PKCQ does not alter the immune response in acute 
muscle injury, where the activity of T cells is not involved, but 
preserves the acute immune response that is important during the 
regenerating process (Lozanoska-Ochser et al ms in prep).  
Together to improving satellite cells maintenance, self-renewal and 
differentiation ability, lack of PKCθ in mdx also improved FAPs 
ability to contribute to muscle repair. In fact, when co-cultured with 
MuSCs FAPs derived from mdxQ-/- muscle exert higher pro-
myogenic activity compared to FAPs derived from mdx muscle. 
Surprisingly, I found that FAPs express high level of PKCQ, when 
cultured both in growing and in pro-adipogenic medium. Moreover, 
I show that FAPs isolated from mdxQ muscle in culture exert ability 
to differentiate into muscle cells and reduced to differentiate into 
adipocytes, in culture, compared to FAPs derived from mdx muscle. 
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Similar ability was observed also when PKCθ was 
pharmacologically inhibited in FAPs isolated from mdx.  
Accordingly, RNA seq analysis showed that FAPs freshly isolated 
from mdxQ-/- muscle expressed high level of genes involved in 
muscle differentiation. The ability of FAPs to differentiate in 
myoblasts is very much controversial. Indeed, it is believed that 
FAPs do not contribute directly to regenerated muscle fibers, but 
support MuSCs behaviour. However, previous studies showed that 
treatment with TSA, an HDAC inhibitor, is able to de-repress a 
‘‘latent’’ myogenic program in FAPs. Thus, the epigenetic changes 
can promote the myogenic potential of FAPs [61]. Interestingly, 
RNAseq showed that the expression of JMJD and SMYD were 
upregulates in FAPs from mdxQ-/-, suggesting that lack of PKCQ 
in dystrophic muscle may induce epigenetic modifications. 
However, further studies will be necessary to discriminate whether 
the observed changes in FAPs phenotype and behavior depends 
primarily to the modified environment or to the lack of PKCQ in 
FAPs. 
Interestingly, lack of PKCQ in mdx, promotes not only the 
regenerative activity of endogenous myogenic cell populations, but 
also the regenerative activity of exogenous transplanted stem cells. 
In fact, lack of PKCΘ in mdx muscle improved MABs survival and 
differentiation in myofibers. I show here that 14 days after 
transplantation, MABs are still detectable in mdxΘ-/- muscle and 
are incorporated into myofibers; by contrast, in mdx muscle MABs 
are detectable up to 7 day, mostly in the interstitial spaces. It is 
conceivable that lack of PKCQ modifying the inflammatory 
environment, favors MABs survival and differentiation ability. On 
top, as being PKCQ involved in allograft response, its lack may 
partly prevent rejection, since the mice were not immune-
suppressed; although the used MABs derived from the same genetic 
background, they express beta-gal which is anyway highly 
immunogenic. Moreover, improved transplanted MABs myogenic 
differentiation within  mdxQ-/- muscle, may also depend, at least in 
part, to the observed increase in Delta1 expression on myofibers. In 
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fact, it was recently shown that the Dll1-Notch1 axis regulates the 
myogenic potential of MABs and ameliorates in vivo MAB-driven 
regeneration [96]. 
Together, these results suggest that lack of PKCQ in dystrophic 
muscle makes a more favourable environment for both endogenous 
and exogenous cell populations to contribute to muscle maintenance 
and repair. This phenotype is probably dependent on modifications 
in the quality of the immune response. However, the obtained results 
may also suggest that PKCQ activity might also directly regulate 
muscle cell populations phenotype, contributing to worsen the 
disease. The underlying mechanisms are under investigation and 
may contribute to the identification of additional molecular / cellular 
targets for intervention aiming to shift the balance between muscle 
regeneration and fibroadipogenic degeneration in DMD and to 
improve cell mediated therapeutic strategies. 
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5. MATERIAL AND METHODS 
 
5.1 Animal models 
PKCθ-/- mice (C57BL/6J background) were provided by Dan 
Littman (New York University, New York). In these mice, the gene 
encoding PKCθ was inactivated in all cells of the body, as 
previously described [98].  
Mdx mice (C57BL/10ScSn-Dmdmdx/J) were purchased from 
Jackson laboratory and mdx PKCθ-/- transgenic mice were 
generated in our laboratory (C57BL/6j-C57BL/10ScSn 
background). C57BL/10ScSn control mice were purchased from 
Jackson laboratory. Only males were used. 
The animals were housed in the Histology Department–accredited 
animal facility. All the procedures were approved by the Italian 
Ministry for Health and were conducted accordingto the U.S. 
National Institutes of Health (NIH) guidelines. 
 
5.2 PCR genotyping 
For genomic DNA PCR, DNA was extract from the Bone Marrow, 
by an ON incubation, at 55°C with agitation, in extracting buffer for 
DNA composed of:1 ml of KCl 2,5M; 0,5 ml of TrisHCl 1M pH 8,4; 
0,1 mg MgCl2 1M; o,225 ml NP40; 0,225 ml Tween 20 ; Proteinase 
K 0,06 mg/ml; and 46,5 ml H2O autoclaved. The day after, incubated 
for 10' at 100°C and centrifuged at 14000 rpm for 10'. After 
centrifugation, the pellet was discarded and the supernatant 
containing DNA was used for PCR analysis. For the PCR, the 
EmeraldAmp®GT PCR Master Mix was used, following the 
manufacturing protocol and for the amplification the PTC-100TM 
thermocycler was used.  
For PKCθ-/- mutation, a 700bp PCR fragment is expected for the 
mutated PKCθ gene, while a 400bp PCR fragment for the WT one. 
Primers: PKCθ-REV: TAAGAGTAATCTTCCAGAGC 
FOR: TTGGTTCTCTTGAACTCTGC 
NEO: ACTGCATCTGCGTGTTCGAA 
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5.3 Muscle injury procedure 
To induce muscle cardiotoxin injury, 10 µl  cardiotoxin (10 µmol in 
H2O, Sigma-Aldrrich) was injected in two different area of the TA 
using a 30 Gauge microsyringe. To induced freeze injury, after skin 
incision and muscle exposition, Tibialis anterior (TA) muscles were 
frozen with three consecutive cycles of freeze-thawing by applying 
for 15 seconds a liquid nitrogen cooled metallic rod. The skin was 
then sutured with 4.0 suture string. 
 
5.4 Mesoangioblast transplantation  
Animals were anesthetized with Avertina. Bilateral intra-femoral 
artery injection was performed with 5 × 105 cells/50 µl saline 
solution, using 32-gauge needles under STEMI SV11 
stereomicroscope (Zeiss, Oberkochen, Germany). Intramuscular 
injection was performed in TA with 5 × 105 cells/50 µl saline 
solution, using 30-gauge needles. 
 
5.5 Cell cultures 
nLacZMabs: nLacZ-Mabs derived from C57/bl6 mice, were gently 
provided by Dr. Cesare Gargioli, Department of Biology, Tor 
Vergata Rome University, Rome, Italy. Mabs were grown in 
Dulbecco's modified Eagle medium (DMEM) supplemented with 
10% FCS (both from Gibco; Invitrogen, Carlsbad, CA, USA) in a 
humidified 5% CO2 atmosphere at 37°C. 
FAPs and MuSCs:  Faps and MuSCs were prepared from limb 
skeletal muscles. Dissected muscles were hashed and then digested 
with 2 µg/ml Collagenase A (Roche), 2.4 U/ml Dispase I (Roche), 
10 ng/ml DNase I (Roche), 0.4 mM CaCl2 and 5 mM MgCl2 for 
90 min at 37°C. After digestion, the obtained cells were washed  
with Dulbecco's phosphate-buffered saline (DPBS) containing 0,2% 
BSA and and then filtered with cell strainer 70 and 40 µm.  Cells 
were incubated with primary antibodies (10 ng/ml) CD31-
PacificBlue (Invitrogen), CD45-eFluor450 (eBioscience), Ter119-
eFluor450 (eBioscience), CD11b-Pacific blue, Sca-1-FITC (BD 
Pharmingen), CD34-Biotin (eBioscience) and α7integrin-APC 
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(kindly provided by Dr. Fabio Rossi) for 30 min on ice. A 
subsequent incubation, 30 min on ice, with Streptavidin-PE-Cy7 
(1/500; BD Pharmingen) was performed. Cells were finally washed 
and resuspended in HBSS containing 0.2% w/v BSA and 1% v/v 
Penicillin–Streptomycin. Flow cytometry analysis and cell sorting 
were performed on a DAKO-Cytomation MoFlo High Speed Sorter. 
Muscle satellite cells (MuSCs) were isolated as 
Ter119−/CD45−/CD31−/CD34+/α7-integrin+/Sca-1− cells; FAPs 
cells were isolated as Ter119−/CD45−/CD31−/CD34+/α7-
integrin−/Sca-1+ cells. FAPs were grown in BIOAMF-2 complete 
medium (ATGC) as a growth medium (GM). After 7 days in GM, 
cells were exposed for 3 days to adipogenic induction medium 
(DMEM containing 10% FBS, 0.5 mM IBMX, 0.25 µM 
dexamethasone and 10 µg/ml insulin), followed by further 3 days in 
adipogenic maintenance medium, (DMEM containing 10% FBS and 
10 µg/ml insulin).  Cell culture inserts with 1.0-µm pore and 12-well 
culture plates (BD bioscience) were used for transwell co-culture. 
Plates were coated with 0.1% gelatin. 4 × 104 freshly sorted MuSCs 
were plated in the bottom of the plate, while 8 × 104 FAPs cells were 
plated on the upper insert. Transwell co-cultures were maintained in 
GM for 7 days and then harvested for analyses.  
FAPs were treated with an PKCQ-specific inhibitor compound 20 
(C20) which was gently provided by Dr. Maryanne Brown 
(BoehringerIngelheim Pharmaceuticals Inc., Ridgefield, CT, USA). 
 Sorted FAPs from 6 week old mdx were plated in BIOAMF-2 
complete medium and treated with C20 (0,5µM-1µM-5µM). After 
15 h, BIOAMF-2 complete medium was changed with adipogenic 
induction medium.  
 
 
5.6 RNA isolation and RT 
For RNA isolation from cells, the cells were collected in TRIsureTM 
(Sigma-Aldrich). For RNA preparation from muscle, the muscles 
were homogenized in Trissure with the ULTRA-TURRAX T25 
(Janke&kunkel IKA Labortechnik) and syringed 4 times with a 21G 
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needle syringe. Then the samples were incubated in TRIsureTM at 
RT for 10 minutes, centrifuged at 12.000 g for 10 minutes at 4°C 
and the pellet was discarded. For every ml of TRIsureTM used, 200ul 
of Chloroform were added. After centrifugation for 15 minutes at 
12000 g, an aqueous phase containing the RNA separates. For every 
ml of TRIsureTM used, 500ul of isopropanol were added to the 
aqueous phase. After 10 minutes of incubation at RT and 
centrifugation for 10 minutes at 12000 g, the RNA precipitates. The 
RNA was aqueous phase as washed with a solution of cold 75 % 
Ethanol in water and then resuspended in RNAse and DNAse free 
water. The RNA was converted in cDNA by a RT PCR. For the RT 
PCR the High-Capacity cDNA RT kit from Applied Biosystem. 
 
5.7 Real time pcr analysis and primer list 
For RT-qPCR analysis the Bioline SensiMixTM SYBR Low-ROX 
Kit was used, following the manufacturer’s protocol. For data 
analysis, the 75000 Software v2.0.5, provided by Applied 
Biosystem,was used. Primer list: 
 
Notch1   
for GGT CGC AAC TGT GAG AGT GA 
rev TTG CTG GCA CAT TCA TTG AT 
Notch2   
for GCA GGA GCA GGA GGT GAT AG 
rev GCG TTT CTT GGA CTC TCC AG 
Notch3   
for GTC CAG AGG CCA AGA GAC TG 
rev CAG AAG GAG GCC AGC ATA AG 
Delta1   
for CCG GCT GAA GCT ACA GAA AC 
rev GAA AGT CCG CCT TCT TGT TG 
Pax7   
for GTCCCAGTCTTACTGCCCAC 
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rev TGTGGACAGGCTCACGTTTT 
MyoD   
for CGACACCGCCTACTACAGTG 
rev GGTGGTGCATCTGCCAAAAG 
Numb   
for CCGGCATGCTCCAATTG 
rev TCTGGCTAAGAGCAGGAAAACC 
MyoG   
for GCATGGAGTTCGGTCCCAA 
rev TATCCTCCACCGTGATGCTG 
GAPDH   
for ACC CAG AAG ACT GTG GAT GG  
rev CAC ATT GGG GGT AGG AAC AC 
LacZ   
for ATCTCTATCGTGCGGTGGTT 
rev GAGCTGACCATGCAGAGGAT) 
 
 
5.8 Western blot 
Cells were homogenized in ice-cold buffer containing 20 mMTris 
(pH 7.5), 2 mM EDTA, 2 mM EGTA, 250 mM sucrose, 5 mM DTT, 
200 mg/ml leupeptin, 10 mg/ml Trasylol, 1 mM PMSF, and 0.1% 
Triton X-100 and then disrupted by sonication. The homogenate was 
incubated for 30 min on ice accompanied by repeated vortexing, 
then centrifuged at 12,000g for 10 min at 4°C. The pellet was 
discarded. An aliquot of the supernatants was used for protein 
determination using the Comassie Plus protein assay reagent 
(Pierce, Rockford, IL), according to the manufacturer's instruction, 
while the remainder was used for Western blot analysis.  An equal 
amount of protein from each sample was loaded onto 10% SDS-
polyacrylamide gels and transferred to a nitrocellulose membrane 
(Schleicher and Schuell, Dassel, Germany). The membranes were 
incubated with PKCQ primary antibodies (Cell signalling). 
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10. RNA sequencing 
Duplicates of mRNA samples isolated from FAPs were sent to the 
IGA technologies services company, which provided us with the 
sequencing results aligned with the genome. The obtained data were 
analysed by Dr. Loredana Le Pera, from ITT, as previously 
described [97].  
 
 
5.9 Statistical analysis 
Quantitative data are presented as means ± SD of at least three 
experiments. Statistical analysis to determine significance was 
performedusing paired Student’s t tests and with ANOVA test. 
Differences were considered to be statistically significant at the p < 
0.05 level. 
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